title: [Prominent efficacy from capecitabine mono-therapy for a case with lymphangiosis carcinomatosa derived from recurrent breast cancer].
abstract: We met a 61-year-old woman who had been suffering from dyspnea due to pleuritis carcinomatosa derived from recurrent breast cancer for which no former chemotherapy had been effective. Capecitabine mono-therapy could exert a drastic anticancer effect for lymphangiosis carcinomatosa causing more severe symptoms of dyspnea. This therapeutic option could be selected for patients with recurrent breast cancer for which the first- or second-line chemotherapy could not provide a sufficient anti-cancer efficacy and possibly serve to sustain the life quality of the patients.
authors.affiliation: Dept. of Surgery, Fukuoka Higashi Medical Center, Japan.
authors.forename: Tadahiro
authors.initials: T
authors.lastname: Nozoe
authors.forename: Emiko
authors.initials: E
authors.lastname: Mori
authors.forename: Mayuko
authors.initials: M
authors.lastname: Kono
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Iguchi
authors.forename: Takashi
authors.initials: T
authors.lastname: Maeda
authors.forename: Akito
authors.initials: A
authors.lastname: Matsukuma
authors.forename: Takahiro
authors.initials: T
authors.lastname: Ezaki
mesh_terms: D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008205:Lymphangitis / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D010998:Pleurisy / Q000188:drug therapy / Q000209:etiology; D011788:Quality of Life; D012008:Recurrence; D014057:Tomography, X-Ray Computed
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil